Antithrombotic therapy in acute coronary syndromes

Guidelines translated for the clinician

Shahyar Gharacholou, Renato D. Lopes, Jeffrey B. Washam, L. Kristin Newby, Stefan K. James, John H. Alexander

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The use of anticoagulant and antiplatelet therapy during the management of acute coronary syndromes (ACS) has been associated with improvements in short-and longterm clinical outcomes, regardless of whether patients are managed conservatively or with acute coronary revascularization. Translating the existing evidence for selection of the most appropriate antithrombotic strategy has been summarized in available guideline recommendations. Given the breadth of antithrombotic recommendations across existing U.S. and European guidelines, synthesis of these recommendations for practicing clinicians who treat patients with ACS are increasingly desired. Providing a summary of the similarities across guidelines while noting the areas where divergence exists becomes an important facet in translating optimal antithrombotic management in ACS for the treating clinician. This review highlights the important aspects of clinical practice guidelines that practicing physicians should consider when selecting antithrombotic therapies to reduce ischemic risk while minimizing hemorrhagic risk across all ACS subtypes.

Original languageEnglish (US)
Pages (from-to)516-528
Number of pages13
JournalJournal of Thrombosis and Thrombolysis
Volume29
Issue number4
DOIs
StatePublished - May 1 2010
Externally publishedYes

Fingerprint

Acute Coronary Syndrome
Guidelines
Therapeutics
Practice Guidelines
Anticoagulants
Physicians

Keywords

  • Acute coronary syndromes
  • Antithrombotic therapy
  • Guidelines

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Antithrombotic therapy in acute coronary syndromes : Guidelines translated for the clinician. / Gharacholou, Shahyar; Lopes, Renato D.; Washam, Jeffrey B.; Newby, L. Kristin; James, Stefan K.; Alexander, John H.

In: Journal of Thrombosis and Thrombolysis, Vol. 29, No. 4, 01.05.2010, p. 516-528.

Research output: Contribution to journalReview article

Gharacholou, Shahyar ; Lopes, Renato D. ; Washam, Jeffrey B. ; Newby, L. Kristin ; James, Stefan K. ; Alexander, John H. / Antithrombotic therapy in acute coronary syndromes : Guidelines translated for the clinician. In: Journal of Thrombosis and Thrombolysis. 2010 ; Vol. 29, No. 4. pp. 516-528.
@article{64e708569c3b4ecd947966ad7d1cc1ea,
title = "Antithrombotic therapy in acute coronary syndromes: Guidelines translated for the clinician",
abstract = "The use of anticoagulant and antiplatelet therapy during the management of acute coronary syndromes (ACS) has been associated with improvements in short-and longterm clinical outcomes, regardless of whether patients are managed conservatively or with acute coronary revascularization. Translating the existing evidence for selection of the most appropriate antithrombotic strategy has been summarized in available guideline recommendations. Given the breadth of antithrombotic recommendations across existing U.S. and European guidelines, synthesis of these recommendations for practicing clinicians who treat patients with ACS are increasingly desired. Providing a summary of the similarities across guidelines while noting the areas where divergence exists becomes an important facet in translating optimal antithrombotic management in ACS for the treating clinician. This review highlights the important aspects of clinical practice guidelines that practicing physicians should consider when selecting antithrombotic therapies to reduce ischemic risk while minimizing hemorrhagic risk across all ACS subtypes.",
keywords = "Acute coronary syndromes, Antithrombotic therapy, Guidelines",
author = "Shahyar Gharacholou and Lopes, {Renato D.} and Washam, {Jeffrey B.} and Newby, {L. Kristin} and James, {Stefan K.} and Alexander, {John H.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1007/s11239-009-0437-9",
language = "English (US)",
volume = "29",
pages = "516--528",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Antithrombotic therapy in acute coronary syndromes

T2 - Guidelines translated for the clinician

AU - Gharacholou, Shahyar

AU - Lopes, Renato D.

AU - Washam, Jeffrey B.

AU - Newby, L. Kristin

AU - James, Stefan K.

AU - Alexander, John H.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - The use of anticoagulant and antiplatelet therapy during the management of acute coronary syndromes (ACS) has been associated with improvements in short-and longterm clinical outcomes, regardless of whether patients are managed conservatively or with acute coronary revascularization. Translating the existing evidence for selection of the most appropriate antithrombotic strategy has been summarized in available guideline recommendations. Given the breadth of antithrombotic recommendations across existing U.S. and European guidelines, synthesis of these recommendations for practicing clinicians who treat patients with ACS are increasingly desired. Providing a summary of the similarities across guidelines while noting the areas where divergence exists becomes an important facet in translating optimal antithrombotic management in ACS for the treating clinician. This review highlights the important aspects of clinical practice guidelines that practicing physicians should consider when selecting antithrombotic therapies to reduce ischemic risk while minimizing hemorrhagic risk across all ACS subtypes.

AB - The use of anticoagulant and antiplatelet therapy during the management of acute coronary syndromes (ACS) has been associated with improvements in short-and longterm clinical outcomes, regardless of whether patients are managed conservatively or with acute coronary revascularization. Translating the existing evidence for selection of the most appropriate antithrombotic strategy has been summarized in available guideline recommendations. Given the breadth of antithrombotic recommendations across existing U.S. and European guidelines, synthesis of these recommendations for practicing clinicians who treat patients with ACS are increasingly desired. Providing a summary of the similarities across guidelines while noting the areas where divergence exists becomes an important facet in translating optimal antithrombotic management in ACS for the treating clinician. This review highlights the important aspects of clinical practice guidelines that practicing physicians should consider when selecting antithrombotic therapies to reduce ischemic risk while minimizing hemorrhagic risk across all ACS subtypes.

KW - Acute coronary syndromes

KW - Antithrombotic therapy

KW - Guidelines

UR - http://www.scopus.com/inward/record.url?scp=77955488707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955488707&partnerID=8YFLogxK

U2 - 10.1007/s11239-009-0437-9

DO - 10.1007/s11239-009-0437-9

M3 - Review article

VL - 29

SP - 516

EP - 528

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

SN - 0929-5305

IS - 4

ER -